PMID: 16522256Mar 9, 2006Paper

Understanding the "lucky few": the conundrum of HIV-exposed, seronegative individuals

Current HIV/AIDS Reports
Barbara L Shacklett

Abstract

It has been known for many years that not all individuals who are repeatedly exposed to HIV-1 show evidence of viral replication, seroconvert, and eventually develop disease. Quite apart from those who seroconvert but progress slowly to AIDS (ie, slow progressors, long-term nonprogressors, elite controllers), these rare, exposed seronegatives either resist infection or harbor extremely low levels of virus that may be detected only using ultrasensitive methods (occult infection). The correlates of protection that confer this unique status to a tiny minority of HIV-exposed individuals remain a subject of intense interest, investigation, and controversy, as no single genetic or immunologic parameter has yet been able to fully explain this phenomenon. However, there is general consensus that studying these individuals may provide invaluable information to aid in the design of vaccines and therapeutic approaches. This review describes the major findings on this important topic, with a focus on immunologic studies.

References

Jan 1, 1995·Nature Medicine·S Rowland-JonesT Corrah
Jan 5, 1994·JAMA : the Journal of the American Medical Association·M ClericiG M Shearer
Mar 14, 1998·The Journal of Infectious Diseases·K S MacDonaldF A Plummer
Nov 5, 1998·The Journal of Clinical Investigation·S L Rowland-JonesF A Plummer
Feb 3, 1999·Proceedings of the National Academy of Sciences of the United States of America·S A StranfordJ A Levy
Jan 21, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·R KaulS L Rowland-Jones
Mar 8, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·L LopalcoA G Siccardi
Oct 25, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·C DevitoJ Hinkula
Feb 13, 2001·The Journal of Clinical Investigation·R KaulF A Plummer
May 26, 2001·The Journal of Clinical Investigation·R KaulS L Rowland-Jones
Jul 21, 2001·Journal of Acquired Immune Deficiency Syndromes : JAIDS·S F LockettA J Leigh Brown
Oct 25, 2002·AIDS Research and Human Retroviruses·Otto O YangJanis V Giorgi
Dec 19, 2002·AIDS Research and Human Retroviruses·Peter F WrightJiri Mestecky
Aug 21, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Florian HladikM Juliana McElrath
Nov 25, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Daniel Scott-AlgaraGianfranco Pancino
Jan 5, 2005·The Journal of Infectious Diseases·Richard A KaslowJames Jianming Tang
Apr 15, 2005·Retrovirology·Yong-Hui Zheng, B Matija Peterlin
Apr 29, 2005·Journal of Virology·Fransje A KoningHanneke Schuitemaker
Jan 28, 2006·The Journal of the Association of Nurses in AIDS Care : JANAC·Suzanne Willard

❮ Previous
Next ❯

Citations

Apr 18, 2009·Current Opinion in HIV and AIDS·Barbara L Shacklett
Jun 15, 2010·Current Opinion in HIV and AIDS·Barbara L Shacklett
Jul 27, 2007·Retrovirology·Juan Lama, Vicente Planelles
Dec 24, 2008·PLoS Neglected Tropical Diseases·Francesco ChecchiDaniel Chandramohan
Feb 13, 2010·Trends in Genetics : TIG·Ping An, Cheryl A Winkler
Jun 30, 2007·Journal of Internal Medicine·T Hirbod, K Broliden
Jun 19, 2013·Immunological Reviews·Huanbin XuRonald S Veazey
Nov 18, 2006·Nature Immunology·Jonathan L Heeney, Stanley A Plotkin
Feb 19, 2010·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Nattawan Promadej-LanierEllen N Kersh
Oct 4, 2020·Annals of the New York Academy of Sciences·Catherine TamaletPhilippe Colson
Feb 2, 2016·Advanced Drug Delivery Reviews·Casey K Hua, Margaret E Ackerman
Jun 15, 2021·Frontiers in Microbiology·Amber D JonesZachary A Klase

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.